1 – 84 of 84
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial
2024) In European Urology(
- Contribution to journal › Article
-
Mark
Eight Misconceptions about Prostate-Specific Antigen
(
- Contribution to journal › Article
- 2023
-
Mark
Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
(
- Contribution to journal › Letter
-
Mark
Deep learning algorithm performs similarly to radiologists in the assessment of prostate volume on MRI
(
- Contribution to journal › Article
-
Mark
Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality : 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial
(
- Contribution to journal › Article
- 2022
-
Mark
Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial
(
- Contribution to journal › Article
-
Mark
PSA : role in screening and monitoring patients with prostate cancer
2022) p.131-172(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2021
-
Mark
Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort
(
- Contribution to journal › Article
- 2020
-
Mark
Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years
(
- Contribution to journal › Article
- 2019
-
Mark
Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men
(
- Contribution to journal › Article
-
Mark
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer : The European Association of Urology Position in 2019
(
- Contribution to journal › Article
-
Mark
Cell-based evidence regarding the role of FSH in prostate cancer
(
- Contribution to journal › Article
-
Mark
The role of plasma microseminoprotein-beta in prostate cancer : An observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition
(
- Contribution to journal › Article
-
Mark
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men
2019) In Prostate(
- Contribution to journal › Article
- 2018
-
Mark
Development of a Sol-gel-assisted Reverse-phase Microarray Platform for Simple and Rapid Detection of Prostate-specific Antigen from Serum
(
- Contribution to journal › Article
-
Mark
Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men
(
- Contribution to journal › Article
-
Mark
Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model : An Individual Patient Data Meta-Analysis
(
- Contribution to journal › Article
-
Mark
Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial : effect of sociodemographic variables on participation, prostate cancer incidence and mortality
(
- Contribution to journal › Article
- 2017
-
Mark
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study
(
- Contribution to journal › Article
-
Mark
Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone : Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above
(
- Contribution to journal › Article
-
Mark
Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts
(
- Contribution to journal › Article
- 2016
-
Mark
Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections
(
- Contribution to journal › Article
-
Mark
Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel
2016) In Journal of Urology(
- Contribution to journal › Article
-
Mark
The profile feasibility study : Targeted screening of men with a family history of prostate cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
(
- Contribution to journal › Article
-
Mark
Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort
(
- Contribution to journal › Article
-
Mark
Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?
(
- Contribution to journal › Article
- 2012
-
Mark
Predicting prostate cancer many years before diagnosis : How and why?
(
- Contribution to journal › Article
- 2011
-
Mark
Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys(145) or Lys(146) from fPSA without internal cleavages at Lys(145) or Lys(146)
(
- Contribution to journal › Article
-
Mark
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
(
- Contribution to journal › Article
-
Mark
TMPRSS2-ERG Status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate
(
- Contribution to journal › Article
-
Mark
Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively
(
- Contribution to journal › Article
- 2010
-
Mark
A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
(
- Contribution to journal › Article
-
Mark
Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy
(
- Contribution to journal › Article
-
Mark
Prostate Specific Antigen Velocity Does Not Aid Prostate Cancer Detection in Men With Prior Negative Biopsy
(
- Contribution to journal › Article
-
Mark
Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: A population-based study from the National Prostate Cancer Register of Sweden
(
- Contribution to journal › Article
-
Mark
Lead-time in the european randomised study of screening for prostate cancer
(
- Contribution to journal › Article
-
Mark
Prostate cancer early detection : Clinical practice guidelines in oncology™
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Prostate-Specific Antigen Velocity for Early Detection of Prostate Cancer: Result from a Large, Representative, Population-based Cohort
(
- Contribution to journal › Article
-
Mark
Prostate Cancer: To Treat or Not to Treat?
(
- Contribution to journal › Article
-
Mark
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Prediction of Survival of Metastatic Prostate Cancer Based on Early Serial Measurements of Prostate Specific Antigen and Alkaline Phosphatase
(
- Contribution to journal › Article
-
Mark
PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
(
- Contribution to journal › Scientific review
-
Mark
The Kallikrein-Related Peptidases hK2 and PSA with Emphasis on Genetic Variation, Secretion, and Sperm Motility
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Screening for prostate cancer : an update.
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy
(
- Contribution to journal › Article
- 2006
-
Mark
Truncated semenogelin I binds zinc and is cleaved by prostate-specific antigen
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
(
- Contribution to journal › Article
-
Mark
Biochemical Studies of Semenogelins with Emphasis on Zinc-Binding Properties
2006)(
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues
(
- Contribution to journal › Article
-
Mark
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade
(
- Contribution to journal › Article
- 2004
-
Mark
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma
(
- Contribution to journal › Article
-
Mark
Lead time associated with screening for prostate cancer
(
- Contribution to journal › Article
-
Mark
The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable
(
- Contribution to journal › Article
-
Mark
Structure, evolution and expression of glandular kallikrein genes
2004)(
- Thesis › Doctoral thesis (compilation)
- 2003
-
Mark
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer
(
- Contribution to journal › Article
-
Mark
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen
(
- Contribution to journal › Article
-
Mark
Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening
(
- Contribution to journal › Article
-
Mark
Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)
(
- Contribution to journal › Article
-
Mark
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
(
- Contribution to journal › Article
-
Mark
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells InVitro or prostate cancer xenografts in vivo
(
- Contribution to journal › Article
- 2002
-
Mark
Exogenous protein kinases A and C, but not endogenous prostasome-associated protein kinase, phosphorylate semenogelins I and II from human semen
(
- Contribution to journal › Article
-
Mark
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen
(
- Contribution to journal › Article
- 2001
-
Mark
Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues
(
- Contribution to journal › Article
- 2000
-
Mark
Time-resolved fluorometry in end-point and real-time PCR quantification of nucleic acids
(
- Contribution to journal › Article
-
Mark
Enzymatic action of prostate-specific antigen (PSA or hK3) : Substrate specificity and regulation by Zn2+, a tight-binding inhibitor
(
- Contribution to journal › Article
- 1999
-
Mark
The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer
(
- Contribution to journal › Article
-
Mark
Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen
(
- Contribution to journal › Article
-
Mark
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen and other serum markers : Current concepts from the world health organization second international consultation on prostate cancer
(
- Contribution to journal › Scientific review
- 1998
-
Mark
Metabolism of free and complexed prostate - specific antigen and their utility for diagnosis and prognosis of prostate cancer
1998)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./Ml. Prostate specific antigen
(
- Contribution to journal › Article
- 1997
-
Mark
Individual prostate-specific antigen (PSA) forms as prostate tumor markers
(
- Contribution to journal › Article
- 1996
-
Mark
A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates : The best case scenario
(
- Contribution to journal › Article
-
Mark
Structural investigation of the alpha-1-antichymotrypsin : Prostate-specific antigen complex by comparative model building
(
- Contribution to journal › Article
- 1991
-
Mark
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
(
- Contribution to journal › Article
- 1990
-
Mark
Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors
(
- Contribution to journal › Article
- 1989
-
Mark
Characterization of the gene for prostate-specific antigen, a human glandular kallikrein
(
- Contribution to journal › Article
- 1987
-
Mark
Molecular cloning of human prostate specific antigen cDNA
(
- Contribution to journal › Article